UNICA IRIS Institutional Research Information System

MULAS, OLGA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 843
NA - Nord America 550
AS - Asia 274
AF - Africa 33
SA - Sud America 33
OC - Oceania 11
Totale 1.744
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 594
US - Stati Uniti d'America 531
DE - Germania 114
CN - Cina 65
IN - India 62
JP - Giappone 29
GB - Regno Unito 23
EG - Egitto 22
FR - Francia 21
AE - Emirati Arabi Uniti 19
BR - Brasile 16
CA - Canada 16
FI - Finlandia 14
NL - Olanda 13
VN - Vietnam 13
ES - Italia 12
AU - Australia 11
CH - Svizzera 11
PK - Pakistan 11
CO - Colombia 10
PL - Polonia 8
UA - Ucraina 8
AZ - Azerbaigian 7
KR - Corea 7
SG - Singapore 7
HK - Hong Kong 6
RU - Federazione Russa 6
TR - Turchia 6
IL - Israele 5
IR - Iran 5
PT - Portogallo 5
ID - Indonesia 4
JO - Giordania 4
MY - Malesia 4
SA - Arabia Saudita 4
TH - Thailandia 4
AR - Argentina 3
CL - Cile 3
CZ - Repubblica Ceca 3
MX - Messico 3
SE - Svezia 3
BD - Bangladesh 2
DZ - Algeria 2
IE - Irlanda 2
IQ - Iraq 2
LB - Libano 2
MV - Maldive 2
TW - Taiwan 2
ZA - Sudafrica 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
MA - Marocco 1
MK - Macedonia 1
NA - Namibia 1
NG - Nigeria 1
PH - Filippine 1
SI - Slovenia 1
SO - Somalia 1
UY - Uruguay 1
Totale 1.744
Salva come PNG Salva come JPEG
Città #
Cagliari 320
Ashburn 61
Columbus 43
Fairfield 37
Santa Cruz 36
Shanghai 33
Seattle 30
Milan 27
Rome 26
Delhi 20
Houston 16
Woodbridge 15
Bengaluru 14
Boardman 14
Cedar Knolls 14
Helsinki 14
Cambridge 13
Buffalo 11
Cairo 11
Bologna 10
Mumbai 10
Chicago 9
Frankfurt am Main 9
Los Angeles 9
Tokyo 9
Wilmington 9
Dong Ket 8
San Diego 8
Baku 7
Santiago de Cali 7
Turin 7
Amsterdam 6
Bari 6
Karachi 6
London 6
Sassari 6
Zurich 6
Ann Arbor 5
Atlanta 5
Council Bluffs 5
Grenoble 5
Hangzhou 5
Las Vegas 5
Melbourne 5
Ottawa 5
Quartucciu 5
Singapore 5
Warsaw 5
Amman 4
Boa Vista 4
Brooklyn 4
Florence 4
Hanoi 4
Lisbon 4
Madrid 4
Manaus 4
Mountain View 4
New York 4
Shenzhen 4
Torino 4
Alexandria 3
Bangkok 3
Bogotá 3
Chennai 3
Chiari 3
Dubai 3
Düsseldorf 3
Esslingen am Neckar 3
Fiesole 3
Gainesville 3
Hyderabad 3
Medesano 3
Montreal 3
Munich 3
Noale 3
Parma 3
Pietra Ligure 3
Providence 3
Qiryat Bialik 3
Riyadh 3
San Jose 3
Santiago 3
Sendai 3
Sorso 3
Tampa 3
Toronto 3
Washington 3
Aikawa 2
Alba 2
Augusta 2
Behshahr 2
Beirut 2
Bischheim 2
Bressanvido 2
Bursa 2
Caerphilly 2
Cardedu 2
Charlotte 2
Chieti 2
Chuncheon 2
Totale 1.103
Salva come PNG Salva come JPEG
Nome #
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study, file e2f56ed9-0ab3-3eaf-e053-3a05fe0a5d97 260
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission, file e2f56ed7-e71a-3eaf-e053-3a05fe0a5d97 161
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors, file e2f56ed9-1277-3eaf-e053-3a05fe0a5d97 110
Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review, file e2f56eda-99eb-3eaf-e053-3a05fe0a5d97 101
Analysis of Early Events during the First Year of Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase - Chronic Myeloid Leukemia: A "Campus CML" Study, file 2a0b3adc-6d97-477f-855a-77611a8b05b4 91
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting, file e2f56ed8-ef9c-3eaf-e053-3a05fe0a5d97 89
The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia, file e6890d92-d86e-49bb-8212-c7e44f4045fb 78
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors, file e2f56ed9-28a7-3eaf-e053-3a05fe0a5d97 66
Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors, file e2f56ed9-f5fc-3eaf-e053-3a05fe0a5d97 61
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine, file 7759f025-e64b-4a33-88f3-365f00c2448c 54
Long-term health-related quality of life in patients with beta-thalassemia after unrelated hematopoietic stem cell transplantation, file dbf54084-84e9-44f6-9349-5999f63ea1e1 49
Risk and Response-Adapted Treatment in Multiple Myeloma, file e2f56ed9-5ada-3eaf-e053-3a05fe0a5d97 49
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors, file 42c6f59c-53c2-42ff-b679-5ea7f559e316 47
Safety and efficacy of caplacizumab retreatment in a real-life monocentric cohort of patients with immune-mediated thrombotic thrombocytopenic purpura, file 9a3fc0a3-7f6e-4c46-990f-986d0f6bfd12 47
Systematic Review and Meta-Analysis of Health-Related Quality of Life in Patients with β-Thalassemia Underwent Hematopoietic Stem Cell Transplantation, file 0019a395-0791-417c-94de-80edea5f6a6f 40
CML-164 Dihydroorotate Dehydrogenase Inhibition Reveals Metabolic Vulnerability in Chronic Myeloid Leukemia, file fcf4e2e9-0624-4cd1-850f-0334e6deb828 33
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia, file 7784ebad-6ea6-45cf-b7e9-e5956fdd35ae 32
Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network, file e2f56eda-413c-3eaf-e053-3a05fe0a5d97 32
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study), file e2f56eda-3857-3eaf-e053-3a05fe0a5d97 29
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart, file e2f56ed9-032c-3eaf-e053-3a05fe0a5d97 27
Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules, file f4bec56c-ec9a-49b1-a8c3-9333485bd781 24
Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib?, file b67af45a-a58e-4652-9a94-2283bb1837c2 21
Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy, file ea9d8f24-a1e2-44c4-957b-154a0193f5a0 21
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML, file e1af067e-cca7-4198-879d-aa01dbd48368 18
Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report, file 4f2d4ec2-644b-4f29-bbf0-5c70dc923036 17
Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation, file 6c92ef65-6cb6-4976-a0b4-7e42f2a77e5e 16
Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome, file e2f56eda-3a15-3eaf-e053-3a05fe0a5d97 16
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study, file e2f56ed9-bcc1-3eaf-e053-3a05fe0a5d97 15
Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials, file e2f56eda-8b6b-3eaf-e053-3a05fe0a5d97 15
Adherence to treatment in patients with solid and hematological cancers. Could spiritual and psychological support facilitate optimal adherence?, file 845cd91e-29bc-4e13-8e22-884d467d2844 14
Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation, file 2d884c2d-eb73-444b-ba1e-7d5fb3f172ce 12
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients, file e2f56ed4-945d-3eaf-e053-3a05fe0a5d97 10
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia, file e2f56eda-cef1-3eaf-e053-3a05fe0a5d97 10
Low adherence to therapy and co-morbid depressive episodes are independent determinants of early death in people with cancer, file 1b308f47-84ea-4e3a-b59a-5e6f789f085e 9
Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis, file e2f56eda-914c-3eaf-e053-3a05fe0a5d97 9
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia, file e2f56ed6-bf64-3eaf-e053-3a05fe0a5d97 7
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors, file e2f56ed8-74a1-3eaf-e053-3a05fe0a5d97 7
Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation, file 4bf92a8d-dc96-48f5-bbd1-43aa5db228bf 6
Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura, file 5e33636e-f095-4eb2-b758-3063481b07a4 6
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients, file e2f56ed3-c8e2-3eaf-e053-3a05fe0a5d97 6
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help, file 51224597-31e3-4974-ab30-3319d210f12c 5
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension, file cdbc2b77-4675-4dcf-a0e4-2db78b1af61c 5
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice, file e2f56ed8-2cc4-3eaf-e053-3a05fe0a5d97 4
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention, file e2f56ed8-3d32-3eaf-e053-3a05fe0a5d97 4
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis, file e2f56ed8-c62a-3eaf-e053-3a05fe0a5d97 4
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib, file e2f56ed9-4ca8-3eaf-e053-3a05fe0a5d97 4
Ruolo del trapianto allogenico nelle talassemie, file e2f56ed9-a6c8-3eaf-e053-3a05fe0a5d97 4
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study, file 2f83a8f3-1fd5-4468-bac4-14fd017bbb6b 2
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia, file 48845738-fdbb-4ff5-a9f6-282539e2fba9 2
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life, file 75e86f1e-9bc8-48c6-bdcc-126fc38338bc 2
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib, file e2ea9990-2ddc-4112-86bc-35654712a7a9 2
Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib, file e2f56ed9-8fec-3eaf-e053-3a05fe0a5d97 2
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis, file e2f56ed9-e61b-3eaf-e053-3a05fe0a5d97 2
Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy, file e2f56eda-917a-3eaf-e053-3a05fe0a5d97 1
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib, file f8917ff0-a3a2-48e4-8457-f6e04eac3666 1
Totale 1.759
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.731
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 7 3
2019/202062 4 1 11 4 4 9 2 4 3 4 3 13
2020/2021313 3 14 7 92 66 25 13 22 26 11 13 21
2021/2022160 14 10 10 2 8 3 9 15 11 16 44 18
2022/2023457 20 9 35 94 37 25 48 43 31 37 51 27
2023/2024742 36 47 62 72 88 68 70 75 52 74 98 0
Totale 1.759